Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kidani

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Chemical & Pharmaceutical Bulletin|March 1, 1979
Antineoplastic activity of platinum complexes of trans-(dl)-1,2-cyclopentanediamineY Kidani, K Inagaki, T Yashiro, et al.
Journal of Medicinal Chemistry|December 1, 1978
Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites formY Kidani, K Inagaki, M Iigo, et al.
Cancer Research|September 1, 1983
Preferential inhibition of the activity of a stimulatory protein of eukaryotic transcription by platinum (II) complexesN Matsumoto, K Sekimizu, M Horikoshi, et al.
Cancer Letters|June 1, 1985
Antitumor activity of l-OHP in miceG Mathé, Y Kidani, M Noji, et al.
Journal of Inorganic Biochemistry|September 1, 1990
The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG)E L Lempers, M J Bloemink, J Brouwer, et al.
Biochimica Et Biophysica Acta|July 30, 1990
Antibodies against (1R,2R)-cyclohexanediamineplatinum(II)-DNA adduct recognize the conformational differences of isomeric analogues of cyclohexanediamineH Yamada, T Kato, J Hirose, et al.
Biochemistry International|March 1, 1984
Selective binding behavior of zinc(II) and copper(II) ions to their native sites of apo-bovine superoxide dismutaseJ Hirose, M Yamada, C Hayakawa, et al.
Biological & Pharmaceutical Bulletin|October 1, 1993
Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligandT Yamashita, J Hirose, M Noji, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1990
Cytotoxicity of asymmetric platinum complexes against L-1210 cells. Effect of bulky substituentsT Hirano, K Inagaki, T Fukai, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1988
Synthesis of Pt(II) complexes containing D-glucuronate, D-gluconate, or their acetyl derivatives and evaluation of antitumor activity against murine leukemia L1210M Noji, M Hanai, T Ohmori, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Chemical & Pharmaceutical Bulletin|March 1, 1979
Antineoplastic activity of platinum complexes of trans-(dl)-1,2-cyclopentanediamineY Kidani, K Inagaki, T Yashiro, et al.
Journal of Medicinal Chemistry|December 1, 1978
Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites formY Kidani, K Inagaki, M Iigo, et al.
Cancer Research|September 1, 1983
Preferential inhibition of the activity of a stimulatory protein of eukaryotic transcription by platinum (II) complexesN Matsumoto, K Sekimizu, M Horikoshi, et al.
Cancer Letters|June 1, 1985
Antitumor activity of l-OHP in miceG Mathé, Y Kidani, M Noji, et al.
Journal of Inorganic Biochemistry|September 1, 1990
The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG)E L Lempers, M J Bloemink, J Brouwer, et al.
Biochimica Et Biophysica Acta|July 30, 1990
Antibodies against (1R,2R)-cyclohexanediamineplatinum(II)-DNA adduct recognize the conformational differences of isomeric analogues of cyclohexanediamineH Yamada, T Kato, J Hirose, et al.
Biochemistry International|March 1, 1984
Selective binding behavior of zinc(II) and copper(II) ions to their native sites of apo-bovine superoxide dismutaseJ Hirose, M Yamada, C Hayakawa, et al.
Biological & Pharmaceutical Bulletin|October 1, 1993
Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligandT Yamashita, J Hirose, M Noji, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1990
Cytotoxicity of asymmetric platinum complexes against L-1210 cells. Effect of bulky substituentsT Hirano, K Inagaki, T Fukai, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1988
Synthesis of Pt(II) complexes containing D-glucuronate, D-gluconate, or their acetyl derivatives and evaluation of antitumor activity against murine leukemia L1210M Noji, M Hanai, T Ohmori, et al.
Pageof 7